Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03595306 · ClinicalTrials.gov registry record · NA
Human Gut Microbiota and Prebiotic Response
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03595306 is a NA study that has completed, run by Duke University. The registered enrollment target is 41 participants.
The verdict
NCT03595306, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study is designed to examine the shift in gut microbiota and their metabolism after consumption of a dietary supplement (prebiotic) by healthy participants. The investigators will provide participants with a panel of over the counter prebiotics and monitor their gut microbiome response in stool. All prebiotics will be commercially available, over-the-counter food, food additives, or dietary supplements, without any known market-use adverse effects beyond minimal discomfort.
Interventions
- DIETARY_SUPPLEMENT Prebiotic A - inulin
- DIETARY_SUPPLEMENT Prebiotic B - galactooligosaccharides(GOS)
- DIETARY_SUPPLEMENT Prebiotic C - wheat dextrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2019-05-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03595306
The ClinicalTrials.gov registry entry for NCT03595306 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Prebiotic A - inulin is the first listed.
NCT03595306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03595306 about?
NCT03595306 is a clinical study titled "Human Gut Microbiota and Prebiotic Response". This study is designed to examine the shift in gut microbiota and their metabolism after consumption of a dietary supplement (prebiotic) by healthy participants. The investigators will provide participants with a panel of over the counter prebiotics and monitor their gut microbiome response in stool...
What is the current status of trial NCT03595306?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2018-05-01. Estimated completion is 2019-05-19.
What interventions are being tested in trial NCT03595306?
The interventions under investigation include: Prebiotic A - inulin (DIETARY_SUPPLEMENT), Prebiotic B - galactooligosaccharides(GOS) (DIETARY_SUPPLEMENT), Prebiotic C - wheat dextrin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03595306?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.